A PROPOSED fire-sale of under-performing food assets failed to stem the blood-letting at Unilever today as the City issued a damning verdict over its failed £50 billion tilt at GlaxoSmithKline.
Shares in the consumer goods titan plunged by more than 7%, erasing some £7 billion from its £100 billion market cap and sending it to the foot of the blue-chip index.
